09 September 2002
Heparin reduces oxidative stress in the postoperative period
Łukasz Dzieciuchowicz, Paweł Chęciński, Hanna KraussMed Sci Monit 2002; 8(9): CR657-660 :: ID: 13491
Abstract
Background: The purpose of our study was to investigate the influence of low-dose heparin on peroxide levels and the antioxidant activity of superoxide dysmutase (SOD), catalase (CAT), and glutathione
peroxidase in the red blood cells of patients undergoing minor abdominal surgery.
Material/Methods: 49 patients scheduled for open cholecystectomy, with a median age of 43, were randomly assigned to either the heparin group (HG) or the placebo group (PG). HG patients received a
subcutaneous dose of 100 IU/kg body weight of standard heparin for 6 days, beginning the first day after surgery. On the day prior to surgery and on the 1st, 2nd and 6th postoperative days, blood samples from peripheral veins were collected, and the levels of peroxides, superoxide dysmutase (SOD), catalase (CAT) and glutathione peroxidase activity in the hemolysate of red blood cells were determined. The level of malondialdehyde was also measured.
Results: Significantly lower levels of peroxides, as well as higher antioxidant activity of SOD and CAT, was found in the erythrocytes of HG patients. Heparin administration did not significantly influence the activity of glutathione peroxidase. There were also no differences in the levels of malondialdehyde between HG and PG patients.
Conclusions: Low-dose standard heparin administered subcutaneously in patients undergoing minor abdominal surgery shows an antioxidant effect. Further studies are required to clarify the mechanism of increased SOD and CAT activity in red blood cells induced by heparin.
Keywords: Anticoagulants - pharmacology, Catalase - blood, Catalase - metabolism, Cholecystectomy, Erythrocytes - enzymology, Glutathione Peroxidase - blood, Heparin - pharmacology, Malondialdehyde - metabolism, Oxidative Stress - drug effects, Peroxides - blood, Postcholecystectomy Syndrome - blood, Superoxide Dismutase - blood, Time Factors
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Database Analysis
Risk Factors of Age-Related Macular Degeneration in a Population-Based Study: Results from SHIP-TREND-1 (St...Med Sci Monit In Press; DOI: 10.12659/MSM.943140
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952